Health officials knew of problem steroids in 2002: U.S. House panel

WASHINGTON (Reuters) – U.S. and Massachusetts state health regulators were aware in 2002 that steroid treatments from the pharmacy at the center of a deadly meningitis outbreak could cause adverse patient reactions, congressional investigators said on Monday. The U.S. House of Representatives Energy and Commerce Committee said complaints about preservative-free methylprednisolone acetate were partly responsible for joint state and federal inspections of the New England Compounding Center’s (NECC) Framingham, Massachusetts facility in 2002 and 2003. …